BNP Paribas Financial Markets’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.66M | Buy |
190,229
+51,365
| +37% | +$718K | ﹤0.01% | 1686 |
|
|
2025
Q1 | $1.87M | Sell |
138,864
-64,989
| -32% | -$876K | ﹤0.01% | 1722 |
|
|
2024
Q4 | $3.91M | Buy |
+203,853
| New | +$3.91M | ﹤0.01% | 1344 |
|
|
2022
Q4 | – | Sell |
-35,445
| Closed | -$727K | – | 3917 |
|
|
2022
Q3 | $727K | Buy |
+35,445
| New | +$727K | ﹤0.01% | 2082 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | -$17 | – | 3617 |
|
|
2020
Q2 | $17 | Sell |
1
-9
| -90% | -$153 | ﹤0.01% | 3626 |
|
|
2020
Q1 | $69 | Hold |
10
| – | – | ﹤0.01% | 3611 |
|
|
2019
Q4 | $74 | Sell |
10
-191
| -95% | -$1.41K | ﹤0.01% | 3670 |
|
|
2019
Q3 | $2.21K | Hold |
201
| – | – | ﹤0.01% | 3705 |
|
|
2019
Q2 | $6.19K | Sell |
201
-167
| -45% | -$5.15K | ﹤0.01% | 3581 |
|
|
2019
Q1 | $15.4K | Buy |
368
+338
| +1,127% | +$14.2K | ﹤0.01% | 3365 |
|
|
2018
Q4 | $1.36K | Sell |
30
-61
| -67% | -$2.77K | ﹤0.01% | 3198 |
|
|
2018
Q3 | $7.59K | Buy |
91
+24
| +36% | +$2K | ﹤0.01% | 3208 |
|
|
2018
Q2 | $6.43K | Sell |
67
-248
| -79% | -$23.8K | ﹤0.01% | 3330 |
|
|
2018
Q1 | $33.1K | Buy |
315
+120
| +62% | +$12.6K | ﹤0.01% | 3170 |
|
|
2017
Q4 | $30.6K | Buy |
195
+113
| +138% | +$17.7K | ﹤0.01% | 3201 |
|
|
2017
Q3 | $11.3K | Sell |
82
-6
| -7% | -$825 | ﹤0.01% | 3288 |
|
|
2017
Q2 | $17.1K | Buy |
+88
| New | +$17.1K | ﹤0.01% | 3197 |
|